Loading company…
Qingdao-based biotechnology company developing rapid nucleic acid detection and point-of-care testing products for healthcare, food safety and animal health.
Founded in 2016 in Qingdao, China, Qingdao Navid Biotechnology Co., Ltd. develops isothermal nucleic acid detection technology for point-of-care testing. Its products include sample release agents, extraction reagents, virus sampling tubes and detection kits for medical, food safety and animal health use, sold to hospitals, universities, regulators and agricultural enterprises. In January 2022 it raised CNY 10 million from Qingdao Gaochuang Investment, with Milestone Capital participating, and it plans to expand into Southeast Asia and Europe by the end of 2023. CEO is Chao Shi.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in